Visus Therapeutics™ is a clinical stage biopharmaceutical company driving advancements in eye health through the development of multi-targeted ophthalmic therapeutics for the front and back of the eye.

Our team is sparking new hope for patients with sight-threatening diseases. We are breaking new ground in treating ocular surface diseases, macular degeneration, glaucoma, presbyopia, and cataracts, with the ultimate goal of helping patients achieve clear vision throughout their lifetimes.